Explores ketamine followed by buprenorphine to sustain reductions in suicidal ideation, suggesting new treatment avenues during crises.
New findings published this month in The American Journal of Psychiatry (AJP) on the use of ketamine followed by ultra‐low‐dose buprenorphine to sustain reductions in suicidal ideation are drawing attention from suicide prevention experts, who say the approach may help address a long‐standing gap in treatment during high‐risk periods following a crisis (see related story, p. 3).
No takes yet. Share an insight, caveat, or question.
Valerie A. Canady (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: